VolitionRX (VNRX US)

VolitionRx Limited operates as an epigenetics company. The Company offers a platform to develop and market blood tests designed to diagnose and monitor a range of life-altering diseases, including certain cancers and diseases associated with NETosis such as sepsis and COVID-19. VolitionRx offers its services in the United Kingdom, United States, Singapore, and Belgium.